The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
Results find delays in care and treatment, fear of exposure to COVID-19 The Neuroendocrine Tumor Research Foundation (NETRF) recently surveyed NET patients and caregivers about
NETRF welcomes two leaders to its Board of Directors. Julie Mebane, Partner, Duane Morris, LLP, and Laurie Rains, Senior Vice President, U.S. Retail Services, Convenience and Liquor Channels, Neilsen. Learn how these new Board members hope to help those living with NETs. (MORE)